ATC Group: P01A Agents against amoebiasis and other protozoal diseases

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of P01A in the ATC hierarchy

Level Code Title
1 P Antiparasitic products, insecticides and repellents
2 P01 Antiprotozoals
3 P01A Agents against amoebiasis and other protozoal diseases

Group P01A contents

Code Title
P01AA Hydroxyquinoline derivatives
P01AB Nitroimidazole derivatives
P01AC Dichloroacetamide derivatives
P01AR Arsenic compounds
P01AX Other agents against amoebiasis and other protozoal diseases

Active ingredients in P01A

Active Ingredient Description
Atovaquone

Atovaquone is a selective and potent inhibitor of the eukaryotic mitochondrial electron transport chain in a number of parasitic protozoa and the parasitic fungus P. jiroveci. The site of action appears to be the cytochrome bc1 complex (complex III).

Chiniofon
Chlorquinaldol
Clioquinol
Diloxanide
Mepacrine
Methronidazole

Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites.

Nitazoxanide
Ornidazole

Ornidazole is indicated for the treatment of Bacterial vaginosis. It is effective against Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia (Giardia intestinalis), and also against certain anaerobic bacteria such as Bacteroides and Clostridium spp., Fusobacterium spp., and anaerobic cocci.

Phanquinone
Secnidazole

Secnidazole is a nitroimidazole antimicrobial drug that displays selectivity against many anaerobic Gram-positive and Gram-negative bacteria and protozoa.

Teclozan
Tenonitrozole
Tilbroquinol
Tilbroquinol and Tiliquinol

Tiliquinol/tilbroquinol combination has amoebicidal action on trophozoites of Entamaeba histolytica under minuta and cystic form.

Tinidazole

Tinidazole is active against both protozoa and obligate anaerobic bacteria. The activity against protozoa involves Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The mode of action of tinidazole against anaerobic bacteria and protozoa involves penetration of the drug into the cell of the micro-organism and subsequent damage of DNA strands or inhibition of their synthesis.

Related product monographs

Title Information Source Document Type  
ALINIA Tablet / Oral suspension FDA, National Drug Code (US) MPI, US: SPL/PLR
FASIGYN Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FLAGYL Suppositories, Oral suspension Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
INTETRIX Capsule Web Search MPI, EU: SmPC
KLONT Immediate release tablets Υπουργείο Υγείας (CY) MPI, EU: SmPC
MEPRON Oral suspension FDA, National Drug Code (US) MPI, US: SPL/PLR
METAGYL Tablet Marketing Authorisation Holder MPI, Generic
METRONIDAZOLE Film-coated tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
METRONIDAZOLE Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
WELLVONE Oral suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC